Teknon Barcelona
| Türkei | Österreich | Spanien | |
| Strahlentherapie bei Darmkrebs | von $7,000 | von $12,000 | von $10,000 |
| Photokoagulation | von $250 | von $750 | von $800 |
| Kryotherapie | von $250 | von $8,000 | von $5,000 |
| Intraarterielle Chemotherapie | von $15,000 | von $15,000 | von $20,000 |
| Hochintensive fokussierte Ultraschallablation (HIFU) | von $4,000 | von $12,000 | von $6,000 |
Dr. Graupera leitet die Abteilung für Hämatologie und Onkologie bei Sant Joan De Déu – einem der führenden Kinderkrankenhäuser Europas. Sein Forschungsschwerpunkt liegt auf der Behandlung von Krebserkrankungen im Kindesalter.
Spezialist für die Behandlung von Retinoblastomen am SJD Barcelona Children's Hospital, mit exklusivem Fokus auf pädiatrische Fälle.
Über 20 Jahre Spezialisierung auf pädiatrische Onkologie – Dr. Lopez Ibor leitet die Abteilung für pädiatrische Hämatologie und Onkologie am HM Montepríncipe.
Über 30 Jahre Erfahrung in der pädiatrischen Onkologie – Dr. Lopez Ibor leitet die Abteilung für Hämatologie und pädiatrische Onkologie bei HM Hospitales mit Schwerpunkt auf der Krebsbehandlung bei Kindern.
Leading Spanish hospitals for pediatric retinoblastoma include SJD Barcelona Children's Hospital and centers in the Quironsalud and HM Hospitales networks. These facilities utilize intra-arterial chemotherapy and proton therapy to treat ocular tumors. Most maintain Joint Commission International accreditation and serve as national reference centers.
Bookimed Expert Insight: Data shows SJD Barcelona Children's Hospital serves 450,000 patients annually and employs 800 doctors. Their lead specialists, like Dr. Jaume Mora Graupera, often hold US fellowships from prestigious institutions like Memorial Sloan Kettering. This combination of massive patient volume and international training typically results in higher success rates for rare pediatric eye tumors.
Patient Consensus: Families emphasize that choosing a center with a dedicated pediatric ocular oncology team is more important than hospital size. They note that centers capable of providing genetic counseling and rapid multidisciplinary care offer the most peace of mind for hereditary cases.
Spain offers advanced eye-sparing treatments like intra-arterial chemotherapy and proton beam therapy to preserve vision and avoid enucleation. Centers like SJD Barcelona Children's Hospital utilize specialized multidisciplinary teams. These clinics focus on high-volume pediatric oncology to ensure the best possible structural and functional outcomes.
Bookimed Expert Insight: Spain’s specialty is the rapid integration of interventional radiology with ocular oncology. SJD Barcelona Children's Hospital performs 14,000 operations annually and serves 450,000 patients. This high volume allows specialists like Dr. Jaume Català Mora to refine complex intra-arterial protocols that are unavailable in smaller regional centers.
Patient Consensus: Patients emphasize that acting quickly is vital for eye preservation. They note that the most effective approach typically combines intra-arterial chemotherapy with focal treatments like lasers.
Genetic counseling and testing are mandatory protocols for retinoblastoma treatment in Spain. Spanish law requires pre-test and post-test counseling for all medical genetic assessments. Specialized pediatric oncology centers integrate these services to confirm RB1 gene mutations and assess family recurrence risks.
Bookimed Expert Insight: Spain’s concentration of pediatric expertise in Barcelona and Madrid creates a high-volume data loop. SJD Barcelona Children's Hospital serves 450,000 patients annually. This massive volume allows specialists like Dr. Jaume Català Mora to refine genetic screening protocols. Their research into molecular pathology directly improves how they handle complex mosaicism cases.
Patient Consensus: Patients emphasize that genetic testing is critical for sibling screening and future family planning. They note that major centers coordinate oncology and genetics together to streamline the diagnostic process.
International patients typically stay in Spain for 7 to 21 days for initial retinoblastoma treatment. This window covers complex diagnostics and specialized procedures like intraarterial chemotherapy. Highly specialized centers in Barcelona and Madrid manage most cases. Stays rarely exceed 90 days without a national visa.
Bookimed Expert Insight: Spain’s top pediatric oncology centers like SJD Barcelona Children's Hospital handle 450,000 patients annually. Our data indicates that while surgeries are brief, total stay length is actually driven by repeated examinations under anesthesia. Dr. Jaume Català Mora and other specialists often require these exams to monitor response. I recommend booking lodging with flexible cancellation because staging results frequently shift the planned discharge date by 48 to 72 hours.
Patient Consensus: Families emphasize that the first visit is often the longest due to urgent workup and coordination between oncology and ophthalmology teams. They suggest keeping travel tickets changeable, as logistical needs often change after the first specialist review.
Spanish oncology teams actively collaborate with local doctors through structured international patient departments. Centers facilitate medical data sharing, virtual tumor boards, and remote second opinions. This ensures a synchronized strategy for retinoblastoma. Local physicians often manage follow-up care using protocols defined by Spanish specialists.
Bookimed Expert Insight: Retinoblastoma cases in Spain show a clear specialization split between Barcelona and Madrid. SJD Barcelona Children’s Hospital treats 450,000 children annually. Their specialists like Dr. Jaume Català Mora focus specifically on retinoblastoma diagnosis. HM Madrid provides access to Dr. Blanca Lopez Ibor with 30+ years of experience. Choosing a clinic with such high pediatric volume often leads to better documentation for home-country specialists.
Patient Consensus: Families emphasize that the handoff is the most critical phase for long-term care. It is vital to request a written surveillance schedule and translated pathology reports before returning home.